Insights from 2023 IMS Annual Meeting
ASH 2023 Insights: "Emapalumab for Treatment of Impending Graft Failure"
By
Insights from 2023 IMS Annual Meeting
FEATURING
Anthony Sabulski
By
Insights from 2023 IMS Annual Meeting
FEATURING
Anthony Sabulski
Login to view comments.
Click here to Login